← Open Payments lookup

NORBERTO TUASON: Open Payments

NPI 1841338555 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,993 in 66 payments from 12 companies in 2025. Trend: 2023 $3,143 · 2024 $595 · 2025 $1,993

Food & beverage: $1,993
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.14$483
Supernus Pharmaceuticals, Inc.23$262
ABBVIE INC.2$247
E.R. Squibb & Sons, L.L.C.9$237
Otsuka America Pharmaceutical, Inc.6$232
Alkermes, Inc.5$182
Axsome Therapeutics, Inc.1$122
Biogen, Inc.1$121
Janssen Pharmaceuticals, Inc2$55
Luye Pharma (USA) Ltd.1$20

Products named: FANAPT, Qelbree, VRAYLAR, COBENFY, REXULTI, ARISTADA, Auvelity, ZURZUVAE.

Industry payments across CA — which companies pay providers there.